.png)
Did you know? The use of mRNA vaccines, originally developed for COVID-19, has opened new avenues in women's health. Researchers are exploring mRNA technology to develop vaccines for conditions like HPV and even breast cancer, potentially leading to new preventive measures and treatments for women’s health issues.
Can mRNA vaccine technology lead to breakthroughs in preventing or treating women's cancers and other reproductive health conditions?
Can mRNA vaccine technology lead to breakthroughs in preventing or treating women's cancers and other reproductive health conditions?
The five-day Menopause Society (formerly the North American Menopause Society) 2024 annual meeting took place Sept. 10 to 14 at the Hyatt Regency in Chicago. The agenda was jam-packed with the latest research in understanding and treating menopausal symptoms, with a special focus on artificial intelligence in the women’s health landscape.
Click the link above to find our postconference wrap-up report.
Taking place at the Hyatt Regency in Chicago, The Menopause Society (formerly North American Menopause Society) is holding its 2024 annual meeting, which spans five days. Attendees are finding it filled with the latest research on understanding and treating menopausal symptoms.
This year’s meeting theme, Humanizing Artificial Intelligence to Improve Midlife Women’s Health, includes actionable advice on the use of artificial intelligence (AI) in clinical practice as well as updates on how AI relates to menopause and midlife women’s health and how future applications may be able to personalize hormone replacement therapy.
Click the link above to find out more about the highlights and programs covered during this years Menopause Society Annual Meeting.
Knee osteoarthritis (OA) shows early sex-specific differences, evident from childhood. This review highlights anatomical differences, youth sports injuries, and metabolic factors contributing to higher OA risk in females. Addressing these early factors may help mitigate future OA severity in women.